|
Description:
|
(1) - Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy
(2) - Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; and companion diagnostics and assays services in the field of gene therapy design and delivery
(3) - Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy; chemical products, reagents, and biomolecules used for scientific and medical purposes
(4) - Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; Gene therapy and phrophylaxis products for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders
(5) - Providing medical services, namely, gene therapy design and delivery services in the field of genetic diseases and disorders, providing medical services, namely, gene therapy design and delivery services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; and pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction
(6) - Providing medical services, namely, gene therapy design and delivery services in the field of genetic diseases and disorders of the liver, gallbladder, and pancreas, providing medical services, namely, gene therapy design and delivery services in the field of liver, hepatological, namely, diseases and disorders of the liver, gallbladder, and pancreas, cardiovascular, endocrine, gastrointestinal, immunological disorders, namely, autoimmune diseases, hypersensitivities, and immune deficiency, acute inflammation and chronic inflammation, menopausal, metabolic diseases, namely, diabetes, hypoglycaemia, gout, and anorexia, autoimmune, musculoskeletal, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, ophthalmologic, respiratory, urogenital, urological, hematologic, and fungal
(7) - Pharmaceutical preparations for the treatment of genetic diseases and disorders of the liver, gallbladder, and pancreas; Pharmaceutical preparations for the treatment of liver, hepatological, namely, diseases and disorders of the liver, gallbladder, and pancreas, cardiovascular, endocrine, gastrointestinal, immunological disorders, namely, autoimmune diseases, hypersensitivities, and immune deficiency, acute inflammation and chronic inflammation, menopausal, metabolic diseases, namely, diabetes, hypoglycaemia, gout, and anorexia, autoimmune, musculoskeletal, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, ophthalmologic, respiratory, urogenital, urological, hematologic, and fungal; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders of the liver, gallbladder, and pancreas; Gene therapy and phrophylaxis products for the treatment of liver, hepatological, namely, diseases and disorders of the liver, gallbladder, and pancreas, cardiovascular, endocrine, gastrointestinal, immunological disorders, namely autoimmune diseases, hypersensitivities, and immune deficiency, acute inflammation and chronic inflammation, menopausal, metabolic diseases, namely, diabetes, hypoglycaemia, gout, and anorexia, autoimmune, musculoskeletal, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, ophthalmologic, respiratory, urogenital, urological, hematologic, and fungal
|